Cargando…

Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis

OBJECTIVE: Liquid chromatography/mass spectrometry (LC/MS)-based comprehensive analysis of metabolic profiles with metabolomics approach has potential diagnostic and predictive implications. However, no metabolomics data have been reported in adult-onset Still’s disease (AOSD). This study investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Der-Yuan, Chen, Yi-Ming, Chien, Han-Ju, Lin, Chi-Chen, Hsieh, Chia-Wei, Chen, Hsin-Hua, Hung, Wei-Ting, Lai, Chien-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179000/
https://www.ncbi.nlm.nih.gov/pubmed/28005947
http://dx.doi.org/10.1371/journal.pone.0168147
_version_ 1782485293436239872
author Chen, Der-Yuan
Chen, Yi-Ming
Chien, Han-Ju
Lin, Chi-Chen
Hsieh, Chia-Wei
Chen, Hsin-Hua
Hung, Wei-Ting
Lai, Chien-Chen
author_facet Chen, Der-Yuan
Chen, Yi-Ming
Chien, Han-Ju
Lin, Chi-Chen
Hsieh, Chia-Wei
Chen, Hsin-Hua
Hung, Wei-Ting
Lai, Chien-Chen
author_sort Chen, Der-Yuan
collection PubMed
description OBJECTIVE: Liquid chromatography/mass spectrometry (LC/MS)-based comprehensive analysis of metabolic profiles with metabolomics approach has potential diagnostic and predictive implications. However, no metabolomics data have been reported in adult-onset Still’s disease (AOSD). This study investigated the metabolomic profiles in AOSD patients and examined their association with clinical characteristics and disease outcome. METHODS: Serum metabolite profiles were determined on 32 AOSD patients and 30 healthy controls (HC) using ultra-performance liquid chromatography (UPLC)/MS analysis, and the differentially expressed metabolites were quantified using multiple reactions monitoring (MRM)/MS analysis in 44 patients and 42 HC. Pure standards were utilized to confirm the presence of the differentially expressed metabolites. RESULTS: Eighteen differentially expressed metabolites were identified in AOSD patents using LC/MS-based analysis, of which 13 metabolites were validated by MRM/MS analysis. Among them, serum levels of lysoPC(18:2), urocanic acid and indole were significantly lower, and L-phenylalanine levels were significantly higher in AOSD patients compared with HC. Moreover, serum levels of lysoPC(18:2), PhePhe, uridine, taurine, L-threonine, and (R)-3-Hydroxy-hexadecanoic acid were significantly correlated with disease activity scores (all p<0.05) in AOSD patients. A different clustering of metabolites was associated with a different disease outcome, with significantly lower levels of isovalerylsarcosine observed in patients with chronic articular pattern (median, 77.0AU/ml) compared with monocyclic (341.5AU/ml, p<0.01) or polycyclic systemic pattern (168.0AU/ml, p<0.05). CONCLUSION: Thirteen differentially expressed metabolites identified and validated in AOSD patients were shown to be involved in five metabolic pathways. Significant associations of metabolic profiles with disease activity and outcome of AOSD suggest their involvement in AOSD pathogenesis.
format Online
Article
Text
id pubmed-5179000
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51790002017-01-04 Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis Chen, Der-Yuan Chen, Yi-Ming Chien, Han-Ju Lin, Chi-Chen Hsieh, Chia-Wei Chen, Hsin-Hua Hung, Wei-Ting Lai, Chien-Chen PLoS One Research Article OBJECTIVE: Liquid chromatography/mass spectrometry (LC/MS)-based comprehensive analysis of metabolic profiles with metabolomics approach has potential diagnostic and predictive implications. However, no metabolomics data have been reported in adult-onset Still’s disease (AOSD). This study investigated the metabolomic profiles in AOSD patients and examined their association with clinical characteristics and disease outcome. METHODS: Serum metabolite profiles were determined on 32 AOSD patients and 30 healthy controls (HC) using ultra-performance liquid chromatography (UPLC)/MS analysis, and the differentially expressed metabolites were quantified using multiple reactions monitoring (MRM)/MS analysis in 44 patients and 42 HC. Pure standards were utilized to confirm the presence of the differentially expressed metabolites. RESULTS: Eighteen differentially expressed metabolites were identified in AOSD patents using LC/MS-based analysis, of which 13 metabolites were validated by MRM/MS analysis. Among them, serum levels of lysoPC(18:2), urocanic acid and indole were significantly lower, and L-phenylalanine levels were significantly higher in AOSD patients compared with HC. Moreover, serum levels of lysoPC(18:2), PhePhe, uridine, taurine, L-threonine, and (R)-3-Hydroxy-hexadecanoic acid were significantly correlated with disease activity scores (all p<0.05) in AOSD patients. A different clustering of metabolites was associated with a different disease outcome, with significantly lower levels of isovalerylsarcosine observed in patients with chronic articular pattern (median, 77.0AU/ml) compared with monocyclic (341.5AU/ml, p<0.01) or polycyclic systemic pattern (168.0AU/ml, p<0.05). CONCLUSION: Thirteen differentially expressed metabolites identified and validated in AOSD patients were shown to be involved in five metabolic pathways. Significant associations of metabolic profiles with disease activity and outcome of AOSD suggest their involvement in AOSD pathogenesis. Public Library of Science 2016-12-22 /pmc/articles/PMC5179000/ /pubmed/28005947 http://dx.doi.org/10.1371/journal.pone.0168147 Text en © 2016 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chen, Der-Yuan
Chen, Yi-Ming
Chien, Han-Ju
Lin, Chi-Chen
Hsieh, Chia-Wei
Chen, Hsin-Hua
Hung, Wei-Ting
Lai, Chien-Chen
Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis
title Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis
title_full Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis
title_fullStr Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis
title_full_unstemmed Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis
title_short Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis
title_sort metabolic disturbances in adult-onset still’s disease evaluated using liquid chromatography/mass spectrometry-based metabolomic analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179000/
https://www.ncbi.nlm.nih.gov/pubmed/28005947
http://dx.doi.org/10.1371/journal.pone.0168147
work_keys_str_mv AT chenderyuan metabolicdisturbancesinadultonsetstillsdiseaseevaluatedusingliquidchromatographymassspectrometrybasedmetabolomicanalysis
AT chenyiming metabolicdisturbancesinadultonsetstillsdiseaseevaluatedusingliquidchromatographymassspectrometrybasedmetabolomicanalysis
AT chienhanju metabolicdisturbancesinadultonsetstillsdiseaseevaluatedusingliquidchromatographymassspectrometrybasedmetabolomicanalysis
AT linchichen metabolicdisturbancesinadultonsetstillsdiseaseevaluatedusingliquidchromatographymassspectrometrybasedmetabolomicanalysis
AT hsiehchiawei metabolicdisturbancesinadultonsetstillsdiseaseevaluatedusingliquidchromatographymassspectrometrybasedmetabolomicanalysis
AT chenhsinhua metabolicdisturbancesinadultonsetstillsdiseaseevaluatedusingliquidchromatographymassspectrometrybasedmetabolomicanalysis
AT hungweiting metabolicdisturbancesinadultonsetstillsdiseaseevaluatedusingliquidchromatographymassspectrometrybasedmetabolomicanalysis
AT laichienchen metabolicdisturbancesinadultonsetstillsdiseaseevaluatedusingliquidchromatographymassspectrometrybasedmetabolomicanalysis